[1]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2016) Cancer Statistics 2015. CA: A Cancer Journal for Clinicians, 66, 7-30.
https://doi.org/10.3322/caac.21332
|
[2]
|
Anderson, W.F., Althuis, M.D., Brinton, L.A., et al. (2004) Is Male Breast Cancer Similar or Different than Female Breast Cancer? Breast Cancer Research and Treatment, 83, 77-86.
https://doi.org/10.1023/B:BREA.0000010701.08825.2d
|
[3]
|
赵敏, 尹菊芬, 龙飞, 林艳苹, 徐学斌, 马永慈, 梅泽超, 王会进. 5917例乳腺癌患者疾病构成特征分析[J]. 中国病案, 2018, 19(3): 63-66.
|
[4]
|
韩小伟, 柳伟伟, 阳泽龙, 李建鹏, 进淑娟, 李念, 左思, 孟迪, 黄焰. 军事医学科学院附属医院乳腺癌临床流行病学16年演变趋势[J]. 中华肿瘤防治杂志, 2016, 23(24): 1597-1600.
|
[5]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[6]
|
李祥, 郑红梅, 何建平, 张敏, 喻满成, 冯尧军, 许娟, 魏少忠, 吴新红. 2012年湖北省乳腺癌发病与死亡情况分析[J]. 肿瘤防治研究, 2018, 45(2): 96-100.
|
[7]
|
Rizzolo, P., Navazio, A.S., Silvestri, V., et al. (2016) Somatic Alterations of Targetable Oncogenes Are Frequently Observed in BRCA1/2 Mutation Negative Male Breast Cancers. Oncotarget, 7, 74097-74106.
https://doi.org/10.18632/oncotarget.12272
|
[8]
|
Silvestri, V., Barrowdale, D., Mulligan, A.M., et al. (2016) Male Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: Pathology Data from the Consortium of Investigators of Modifiers of BRCA12. Breast Cancer Research, 18, 15.
|
[9]
|
穆旭东, 赵文辉. 男性乳腺癌研究进展[J]. 新乡医学院学报, 2016, 33(2): 153-156.
|
[10]
|
Krause, W. (2004) Male Breast Cancer: An Andrological Disease: Risk Factors and Diagnosis. Andrologia, 36, 346-354. https://doi.org/10.1111/j.1439-0272.2004.00639.x
|
[11]
|
卢林捷, 孔令泉. 乙型肝炎病毒感染与乳腺癌关系的初步l临床研究[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2015.
|
[12]
|
孔令泉, 吴凯南. 乳腺肿瘤肝病学概述[M]//孔令泉, 吴凯南, 厉红元, 主编. 乳腺肿瘤肝病学. 北京: 科学出版社, 2017.
|
[13]
|
Abrams, M.J., Koffer, P.P., David, E., et al. (2017) Postmastectomy Radiation Therapy Is Associated with Improved Survival in Nodepo-Sitive Male Breast Cancer: A Population Analysis. International Journal of Radiation Oncology, Biology, Physics, 98, 384-391. https://doi.org/10.1016/j.ijrobp.2017.02.007
|
[14]
|
Keinan-Boker, L., Levine, H., Leiba, A., et al. (2018) Adolescent Obesity and Adult Male Breast Cancer in a Cohort of 1,382,093 Men. International Journal of Cancer, 142, 910-918. https://doi.org/10.1002/ijc.31121
|
[15]
|
刘新丽, 刘芳芳, 郑屹, 等. 男性乳腺癌临床病理特征及预后分析[J]. 中国肿瘤临床, 2014, 41(23): 1521-1526.
|
[16]
|
王翔宇, 方仪, 杨雪, 等. 男性乳腺癌的临床病理特征及生存分析[J]. 临床肿瘤学杂志, 2016, 21(4): 340-344.
|
[17]
|
Abhyankarn, Hoskinskf, Abernmr, et al. (2017) Descriptive Characteristics of Prostate Cancer in Patients with a History of Primary Male Breast Cancer: A SEER Analysis. BMC Cancer, 17, 659.
|
[18]
|
Khanmh, Allertonr and Pettitl (2015) Hormone Therapy for Breast Cancer in Men. Clinical Breast Cancer, 15, 245-250.
|
[19]
|
焦武, 姚峰. 男性乳腺癌的研究进展[J]. 中华实用诊断与治疗杂志, 2018, 32(5): 518-520.
|
[20]
|
唐中华, 李允山. 现代乳腺甲状腺外科学[M]. 长沙: 湖南科学技术出版社, 2011.
|
[21]
|
Eggemann, H., Ignatov, A., Stabenow, R., et al. (2013) Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy. Breast Care, 8, 270-275. https://doi.org/10.1159/000354122
|
[22]
|
Hayes (2009) Pharmacologic Treatment of Male Breast Cancer. Expert Opinion on Pharmacotherapy, 10, 2499-2510.
https://doi.org/10.1517/14656560903200634
|
[23]
|
Hershman, D.L., Tsui, J., Meyer, J., et al. (2014) The Change from Brand-Name to Generic Aromatase Inhibitors and Hormone Therapy Adherence for Earlystage Breast Cancer. Journal of the National Cancer Institute, 106, dju319.
https://doi.org/10.1093/jnci/dju319
|
[24]
|
Arslan, U.Y., Oksuzoglu, B., Ozdemir, N., et al. (2012) Outcome of Non-Metastatic Male Breast Cancer: 118 Patients. Medical Oncology, 29, 554-560. https://doi.org/10.1007/s12032-011-9978-9
|
[25]
|
Hayashi, H., Kimura, M., Yoshimoto, N., et al. (2009) A Case of HER2-Positive Male Breast Cancer with Lung Metastases Showing a Good Response to Trastuzumab and Paclitaxel Treatment. Breast Cancer, 16, 136-140.
https://doi.org/10.1007/s12282-008-0060-1
|
[26]
|
鲁英, 刘佩, 唐金海. 男性乳腺癌的研究现状[J]. 中国肿瘤外科杂志, 2017, 9(4): 264-267.
|